REUTERS/Brendan McDermidByron Wien.Stocks have catapulted through recovery.Among the things that have driven the expansion, a key factor has been the role of the Federal Reserve.In market commentary Wednesday, Blackstone’s Byron Wien pegs a number on this: $3 trillion.Even though we’ve seen company earnings more than double between 2009 and 2014, there has been concern that the market rally has largely […]
Wikimedia CommonsMorgan Stanley’s US equity strategy team published a note Monday titled “We Are Full of Bull.”In it, strategist Adam Parker identifies a multitude of reasons to be bullish.However, many of the more bearish folk continue to point to the S&P 500’s price-to-forward-earnings ratio (P/E), which at 17x is not reflective of a cheap market.Parker actually believes the stock market […]
View All3 Potent Biotech Stocks That Could Pop on EarningsLike golf, investing in biotech stocks can be cruel game. As Michael A. Gayed explains, the pricing dynamic of individual biotech stocks will often follow the perceived successes — or failures — of drug trials and the multiple approval procedures enforced by regulatory agencies.Source: ©iStock.com/twilightproductionsThis Wild West mentality is primarily the […]
Stock Market April Cycle LowStock-Markets / Cycles AnalysisApr 21, 2015 – 06:04 PM GMTBy: Ed_CarlsonAlthough my Hybrid Lindsay forecasts always assume a small time window surrounds any single-date point forecast, the forecast for a high on April 15 (see last week’s commentary) was spot-on. The work of George Lindsay deals with time (not price) and tells us that the pullback […]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
Miami, FL — (ReleaseWire) — 01/14/2015 — Investing in marijuana stocks as been referred to in the past as the “green rush”, especially after Colorado and Washington became the first states to legalize recreational cannabis. Businesses with no experience in the cannabis circuit were trying to move in to make some green of their own. Savvy penny stock investors soon […]
Bloomberg TelevisionGoldman Sachs’ David KostinSee AlsoGOLDMAN: Here Are The 15 Best Stocks For Fat Dividends And Huge BuybacksGOLDMAN: Everybody In Texas Is Resigned To Lower Oil PricesUBS On Stocks: ‘Roll Tide, Roll…’Goldman Sachs equity strategist David Kostin is out with his 2015 outlook for the S&P 500.Kostin’s price target: 2,100.This equates to a roughly 5% return for the benchmark stock […]
Read Full Article ››TAGGED:Stocks
RECOMMENDED ARTICLES
August 6, 2014The 10 Cheapest & Most Expensive S&P 500 StocksJoshua Brown
August 6, 2014What This Death Cross Says about Market WeaknessJeff Cox, CNBC
Multiple theories have been put for for the recent stock market weakness, none of them particularly satisfying. more »
August 5, 2014Do Not Buy This Dip: The Fed Ain’t Your FriendDavid Stockman, SA
During the last […]
Jul 23Three Reasons to Trade OptionsPosted in Stock Option Email This Post
Sharebar
Many investors are afraid of option trading due to the high risk. There is no shortage of horror stories of traders getting wiped out when irresponsibly option trading.Options are like any other financial tool. Using them responsibly can greatly enhance your returns. Use options irresponsibly they can wipe you […]
